Search

Your search keyword '"Cross, Justin R."' showing total 399 results

Search Constraints

Start Over You searched for: Author "Cross, Justin R." Remove constraint Author: "Cross, Justin R."
399 results on '"Cross, Justin R."'

Search Results

3. Altered microbial bile acid metabolism exacerbates T cell-driven inflammation during graft-versus-host disease

6. Connecting copper and cancer: from transition metal signalling to metalloplasia

10. Alloreactive T cells deficient of the short-chain fatty acid receptor GPR109A induce less graft-versus-host disease

11. Characterization, structure and inhibition of the human succinyl-CoA:glutarate-CoA transferase, a genetic modifier of glutaric aciduria type 1

13. A High-Fiber Dietary Intervention (NUTRIVENTION) in Precursor Plasma Cell Disorders Improves Disease Biomarkers and Delays Progression to Myeloma

16. Metabolic adaptation of acute lymphoblastic leukemia to the central nervous system microenvironment depends on stearoyl-CoA desaturase

18. Microbiota modulate sympathetic neurons via a gut–brain circuit

22. Microbiota-derived lantibiotic restores resistance against vancomycin-resistant Enterococcus

27. Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations

28. Data from Serine Catabolism Regulates Mitochondrial Redox Control during Hypoxia

29. Supplementary Table 1 from Serine Catabolism Regulates Mitochondrial Redox Control during Hypoxia

30. Data from Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia

31. Figure S1, Figure S2, Figure S3, Figure S4 from Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia

32. Supplementary Figure 5 from Serine Catabolism Regulates Mitochondrial Redox Control during Hypoxia

33. Supplementary Figure 2 from Serine Catabolism Regulates Mitochondrial Redox Control during Hypoxia

34. Supplementary Figure 4 from Serine Catabolism Regulates Mitochondrial Redox Control during Hypoxia

35. Supplementary Figure 1B from Serine Catabolism Regulates Mitochondrial Redox Control during Hypoxia

36. Table S1, Table S2, Table S3, Table S4 from Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia

37. Supplementary Figure 3 from Serine Catabolism Regulates Mitochondrial Redox Control during Hypoxia

38. Supplemental Figure 5 from Mitochondrial Inhibition Augments the Efficacy of Imatinib by Resetting the Metabolic Phenotype of Gastrointestinal Stromal Tumor

39. Supplemental Figure 1 from Mitochondrial Inhibition Augments the Efficacy of Imatinib by Resetting the Metabolic Phenotype of Gastrointestinal Stromal Tumor

40. Supplemental Fig.1-4;Supplemental Tables 1-3; Suipplemental Methods from Molecular and Clinical Effects of Notch Inhibition in Glioma Patients: A Phase 0/I Trial

41. Supplemental Figure 3 from Mitochondrial Inhibition Augments the Efficacy of Imatinib by Resetting the Metabolic Phenotype of Gastrointestinal Stromal Tumor

42. Supplemental Figure 4 from Mitochondrial Inhibition Augments the Efficacy of Imatinib by Resetting the Metabolic Phenotype of Gastrointestinal Stromal Tumor

43. Supplemental Figure 2 from Mitochondrial Inhibition Augments the Efficacy of Imatinib by Resetting the Metabolic Phenotype of Gastrointestinal Stromal Tumor

44. Microbial Bile Acid Metabolism Shapes Effector T Cell Responses during Graft-Versus-Host Disease in Mouse and Human

45. Acyl‐CoA dehydrogenase substrate promiscuity: Challenges and opportunities for development of substrate reduction therapy in disorders of valine and isoleucine metabolism.

46. Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease

47. A Pilot Plant Based Dietary Intervention in MGUS and SMM Patients with Elevated BMI Is Feasible and Associated with Improvements in Metabolic and Microbiome Biomarkers of Progression

48. A Randomized Placebo Controlled Study of a Plant-Based Dietary Versus Supplement Versus Placebo Intervention in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Multiple Myeloma (SMM) - the Nutrition Prevention (NUTRIVENTION-3) Study

49. Fructose Treatment Targets Myeloid Leukemogenesis in IDH2 Mutants By Exhausting Alpha-Ketoglutarate Pools

50. Ogdh Is a Genetic Vulnerability and Therapeutic Target in Acute Myeloid Leukemia

Catalog

Books, media, physical & digital resources